Albert David Limited has informed the Exchange that Record date for the purpose of Dividend & 87th AGM Meeting is 30-Jul-2026.
ALBERTDAVD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 10.1 pts less than Nifty Microcap 250 and 9.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Albert David Limited's board meeting on May 12, 2026 approved the appointment of Mr. Amit Mahla as CEO effective that date, filling a vacancy left by Mr. Umesh Manohar Kunte's resignation as Managing Director & CEO since December 18, 2025. The company also reported audited financial results for FY2026 with an unmodified audit opinion from L.B. Jha & Co., showing a significant decline in profit before tax to Rs. 52.49 lakhs from Rs. 2,522.77 lakhs in FY2025. The board recommended a final dividend of Rs. 5 per share (50% on Rs. 10 face value) for shareholder approval at the 87th AGM scheduled for August 6, 2026, with July 30, 2026 as the record date. PwC Services LLP and S. Gupta & Co. were re-appointed as internal and cost auditors respectively for FY2026-27.
The appointment of a new CEO with extensive pharma industry experience from leading companies may provide positive sentiment, though the sharp decline in annual profitability (down 98% YoY) and negative Q4 results may concern investors in the near term.